Antimicrobial Activity of Malaysian Apis mellifera Propolis against Propionibacterium acnes

@#Introduction: Acne vulgaris is a common skin disease that affects people all over the world. One of the main pathogenesis of acne is Propionibacterium acnes (P. acnes) proliferation. Propolis has long been used in folk medicine as a natural remedy. Its antimicrobial properties have all been studied extensively. However, there have been few studies on its use in acne. Thus, the goal of this study was to assess the antimicrobial potential of ethanolic (EEP) and water extracts (WEP) of Malaysian Apis mellifera propolis against P. acnes. Methods: Propolis samples were collected from Acacia mangium apiary from northern and southern regions of Peninsular Malaysia. The propolis extracts were screened for antimicrobial activity against P. acnes using an agar well diffusion assay. The minimum inhibitory concentrations (MICs) of the extracts were determined using a resazurin broth microdilution assay. Results: The antimicrobial screening demonstrated all extracts had antimicrobial activity against P. acnes. The inhibition zones at concentration 20 mg/ml were in the range of 16 mm to 24 mm which was greater than positive control (10% benzoyl peroxide) (15 mm). The EEP from northern region showed the lowest MIC values (0.32 µg/ml), followed by EEP from southern region (0.63 µg/ml), WEP from southern region (625 µg/ml) and WEP from northern region (2500 µg/ml). Conclusion: The Malaysian EEP demonstrated promising antimicrobial properties against P. acnes. Further study is needed to determine the active constituents and their possible inhibitory mechanisms against P. acnes.

Achievement of LDL Cholesterol Goal and Adherence to Statin by Diabetes Patients in Kelantan

Background: Statins are a class of potent drugs that can be used to reduce cholesterol, especially low-density lipoprotein cholesterol (LDL-C). However, their effectiveness is limited if adherence to treatment is poor. The objectives of the study are to estimate the proportion of diabetic patient who has achieved LDL-C goal and to determine the association of LDL-C achievement with socio demographic factors and statin therapy adherence Methods: This is a cross-sectional study involving 234 patients with type 2 diabetes mellitus (T2DM) and dyslipidaemia attending an outpatient clinic in a hospital in Kelantan. Interviews and self-administered questionnaires were used to determine their sociodemographic and clinical characteristics. Adherence to therapy was assessed using the Medication Compliance Questionnaire (MCQ). The associations between the achievement of LDL targets and sociodemographic/clinical factors, including adherence, were analysed with simple logistic regression. Results: About 37.6% of patients achieved their LDL-C target. The percentage of patients who adhered to statin use was 98.3%, and 20.5% of these patients reported full adherence. There was no significant association between achievement of LDL-C targets with adherence or any other sociodemographic factors, such as age, gender and educational or economic status (all P-value < 0.05). Conclusion: Despite a high level of adherence, the majority of patients failed to achieve LDL-C targets. More concerted efforts are needed to improve this.